Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20610636 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis
Condition: Pulmonary Tuberculosis
Interventions: Drug: Rifapentine;   Drug: Isoniazid

Indicates status has not been verified in more than two years